3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3092SP |
Moricizine, Serum/Plasma |
3118B |
Nateglinide, Blood |
3118SP |
Nateglinide, Serum/Plasma |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3532B |
Phencyclidine Screen, Blood |
3532FL |
Phencyclidine Screen, Fluid |
3532SP |
Phencyclidine Screen, Serum/Plasma |
3532U |
Phencyclidine Screen, Urine |
3779B |
Pioglitazone, Blood |
3779SP |
Pioglitazone, Serum/Plasma |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |